Overexpression, activating mutations, and autocrine stimulation of ErbB-family receptors—particularly EGFR and HER2—can lead to uncontrolled cell division via activation of multiple downstream signaling pathways [19–21], which is particularly common in breast and lung cancers. The gene discussed is EGFR; the disease is lung cancer.